RS

Rishi Singh Bhadoria

Active Director Director DIN 09046894
DIN 09046894 First appointment Jan 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2021
Shareholding value •••• Premium profile

About Rishi Singh Bhadoria

Data last updated:

Rishi Singh Bhadoria is a Director at Mancare Remedies Private Limited (since 2021). The company operates in Pharma. Mancare Remedies Private Limited reported revenue of ₹3.79 Cr (FY 2025).

DIN 09046894
Primary Designation Director
Industry Pharma
First Appointment 30 Jan 2021
Oldest Company Age 17 yrs
Largest company Mancare Remedies Private Limited · ₹3.79 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mancare Remedies Private Limited U24232MP2009PTC022309
Director30 Jan 20212009₹3.79 Cr (FY 2025)Active

Board colleagues of Rishi Singh Bhadoria

Directorship timeline

Open interactive timeline →
Mancare Remedies Private Limited
Premium access

Shareholding and investment profile for Rishi Singh Bhadoria

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rishi Singh Bhadoria

Rishi Singh Bhadoria currently holds 1 directorship: Mancare Remedies Private Limited (Director, since 30 Jan 2021, revenue ₹3.79 Cr (FY 2025)).

Rishi Singh Bhadoria was first appointed on 30 Jan 2021 as Director at Mancare Remedies Private Limited.

The current boards of Rishi Singh Bhadoria's companies include Monika Tomar (Mancare Remedies Private Limited), Prashant Gupta (Mancare Remedies Private Limited), Satyendra Mishra (Mancare Remedies Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available